Indication
Complicated Pseudomonas aeruginosa peritonitis
Complicated *Pseudomonas aeruginosa* peritonitis is a severe intra-abdominal infection characterized by inflammation of the peritoneum that extends beyond the initial organ source into the peritoneal cavity, involving abscess formation, visceral perforation, or extensive tissue necrosis. Read more about Complicated Pseudomonas aeruginosa peritonitis
86 drugs 62 manufacturers
Drugs that treat it
Common Complicated Pseudomonas aeruginosa peritonitis therapies.
CIPROFLOXACIN HCL
CIPROFLOXACIN HCL
CIPROFLOXACIN HCL
CIPROFLOXACIN HCL
CEFEPIME HCL
CIPROFLOXACIN HCL
CIPROFLOXACIN HCL
CIPROFLOXACIN HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonComplicated *Pseudomonas aeruginosa* peritonitis is a severe intra-abdominal infection characterized by inflammation of the peritoneum that extends beyond the initial organ source into the peritoneal cavity, involving abscess formation, visceral perforation, or extensive tissue necrosis.
Commonly arising in hospitalized, postsurgical, or peritoneal dialysis patient populations, this condition is driven by the opportunistic, Gram-negative pathogen *Pseudomonas aeruginosa*.
Pathophysiologically, the organism employs robust virulence factors and biofilm formation that provoke intense peritoneal inflammation, often presenting with abdominal rigidity, purulent or cloudy peritoneal effluent, fever, and sepsis.
Because *P.
aeruginosa* frequently exhibits intrinsic and acquired multidrug resistance, these infections are associated with poor initial response to antimicrobial monotherapy, secondary complications such as encapsulating fibrosis or abscess loculation, and high rates of procedural source-control failure.
- aafp.org
Complicated *Pseudomonas aeruginosa* peritonitis is a severe intra-abdominal infection characterized by inflammation of the peritoneum that extends beyond the initial organ source into the peritoneal cavity, involving abscess formation, visceral perforation, or extensive tissue necrosis
- mdpi.com
Commonly arising in hospitalized, postsurgical, or peritoneal dialysis patient populations, this condition is driven by the opportunistic, Gram-negative pathogen *Pseudomonas aeruginosa*
- ucsf.edu
Commonly arising in hospitalized, postsurgical, or peritoneal dialysis patient populations, this condition is driven by the opportunistic, Gram-negative pathogen *Pseudomonas aeruginosa*
- asm.org
Pathophysiologically, the organism employs robust virulence factors and biofilm formation that provoke intense peritoneal inflammation, often presenting with abdominal rigidity, purulent or cloudy peritoneal effluent, fever, and sepsis
- nih.gov
Pathophysiologically, the organism employs robust virulence factors and biofilm formation that provoke intense peritoneal inflammation, often presenting with abdominal rigidity, purulent or cloudy peritoneal effluent, fever, and sepsis
- ispd.org
Pathophysiologically, the organism employs robust virulence factors and biofilm formation that provoke intense peritoneal inflammation, often presenting with abdominal rigidity, purulent or cloudy peritoneal effluent, fever, and sepsis
- nih.gov
Because *P. aeruginosa* frequently exhibits intrinsic and acquired multidrug resistance, these infections are associated with poor initial response to antimicrobial monotherapy, secondary complications such as encapsulating fibrosis or abscess loculation, and high rates of procedural source-control failure
- nih.gov
Because *P. aeruginosa* frequently exhibits intrinsic and acquired multidrug resistance, these infections are associated with poor initial response to antimicrobial monotherapy, secondary complications such as encapsulating fibrosis or abscess loculation, and high rates of procedural source-control failure
Personalize your experience
Follow Complicated Pseudomonas aeruginosa peritonitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.